Chronic Urticaria: Comparisons of US, European, and Asian Guidelines

[1]  M. Maurer,et al.  Cyclosporine for Chronic Spontaneous Urticaria: A Meta-Analysis and Systematic Review. , 2017, The journal of allergy and clinical immunology. In practice.

[2]  T. Zuberbier,et al.  Responsiveness and minimal important difference of the urticaria control test , 2017, The Journal of allergy and clinical immunology.

[3]  Ling Meng,et al.  Omalizumab for the treatment of chronic spontaneous urticaria: A meta-analysis of randomized clinical trials. , 2016, The Journal of allergy and clinical immunology.

[4]  M. Kowalski,et al.  Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug-related urticaria and angioedema. , 2015, The Journal of allergy and clinical immunology.

[5]  Michihiro Hide,et al.  The EAACI/GA 2 LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update , 2015 .

[6]  J. Bernstein,et al.  Investigation of patient-specific characteristics associated with treatment outcomes for chronic urticaria. , 2015, The journal of allergy and clinical immunology. In practice.

[7]  T. Zuberbier,et al.  Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria. , 2014, Allergy.

[8]  T. Zuberbier,et al.  The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. , 2014, Allergy.

[9]  T. Casale,et al.  Development and validation of the Urticaria Control Test: a patient-reported outcome instrument for assessing urticaria control. , 2014, The Journal of allergy and clinical immunology.

[10]  J. Sheikh,et al.  The diagnosis and management of acute and chronic urticaria: 2014 update. , 2014, The Journal of allergy and clinical immunology.

[11]  P. Martus,et al.  Development, validation, and initial results of the Angioedema Activity Score , 2013, Allergy.

[12]  D. Khan.  Alternative agents in refractory chronic urticaria: evidence and considerations on their selection and use. , 2013, The journal of allergy and clinical immunology. In practice.

[13]  T. Casale,et al.  Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. , 2013, The New England journal of medicine.

[14]  T. Zuberbier,et al.  Diagnosis and Treatment of Urticaria and Angioedema: A Worldwide Perspective , 2012, The World Allergy Organization journal.

[15]  S. Chow.  Management of chronic urticaria in Asia: 2010 AADV consensus guidelines , 2012, Asia Pacific allergy.

[16]  T. Hiragun,et al.  Japanese guidelines for diagnosis and treatment of urticaria in comparison with other countries. , 2012, Allergology International.

[17]  David M Lang,et al.  Utility of routine laboratory testing in management of chronic urticaria/angioedema. , 2011, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[18]  S. Spector,et al.  A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria. , 2011, The Journal of allergy and clinical immunology.

[19]  J. Bousquet,et al.  Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report 1 , 2011, Allergy.

[20]  T. Zuberbier,et al.  Epidemiology of urticaria: a representative cross‐sectional population survey , 2010, Clinical and experimental dermatology.

[21]  T. Zuberbier,et al.  Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi‐centre, double‐blind, randomized, placebo‐controlled study , 2010, Allergy.

[22]  Todor A Popov,et al.  The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria. , 2010, The Journal of allergy and clinical immunology.

[23]  T. Zuberbier,et al.  Effects of a pseudoallergen‐free diet on chronic spontaneous urticaria: a prospective trial , 2010, Allergy.

[24]  A. Finlay,et al.  Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients , 2009, Allergy.

[25]  G. Di Fede,et al.  Leukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: a systematic review , 2008, Journal of asthma and allergy.

[26]  T. Zuberbier,et al.  How to assess disease activity in patients with chronic urticaria? , 2008, Allergy.

[27]  R. Asero.  Etoricoxib challenge in patients with chronic urticaria with NSAID intolerance , 2007, Clinical and experimental dermatology.

[28]  P. Correll,et al.  Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993-1994 to 2004-2005. , 2007, The Journal of allergy and clinical immunology.

[29]  M. Greaves,et al.  Chronic Urticaria: Recent Advances , 2007, Clinical reviews in allergy & immunology.

[30]  R. Asero.  Chronic unremitting urticaria: is the use of antihistamines above the licensed dose effective? A preliminary study of cetirizine at licensed and above‐licensed doses , 2006, Clinical and experimental dermatology.

[31]  G. Vena,et al.  Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. , 2006, Journal of the American Academy of Dermatology.

[32]  Y. Kameyoshi,et al.  The effectiveness of montelukast for the treatment of anti-histamine-resistant chronic urticaria , 2005, Archives of Dermatological Research.

[33]  E. Nettis,et al.  Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double‐blind, placebo‐controlled study , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[34]  E. Sabo,et al.  Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients , 2004, Allergy.

[35]  S. Dogra,et al.  Comparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticaria , 2004, The Journal of dermatological treatment.

[36]  R. Bödeker,et al.  Treatment of chronic urticaria with terfenadine and ranitidine , 1986, European Journal of Clinical Pharmacology.

[37]  J. Bernstein,et al.  The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results. , 2004, The Journal of allergy and clinical immunology.

[38]  J. A. Grant,et al.  A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects. , 2002, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[39]  A. Kaplan.  Clinical practice. Chronic urticaria and angioedema. , 2002, The New England journal of medicine.

[40]  E. Nettis,et al.  Comparison of montelukast and fexofenadine for chronic idiopathic urticaria. , 2001, Archives of dermatology.

[41]  P. Seed,et al.  Randomized double‐blind study of cyclosporin in chronic ‘idiopathic’ urticaria , 2000, The British journal of dermatology.

[42]  Kaiping Yang,et al.  Placental 11 beta-hydroxysteroid dehydrogenase: barrier to maternal glucocorticoids. , 1997, Reviews of reproduction.

[43]  M. Morgan,et al.  The impact of chronic urticaria on the quality of life , 1997, The British journal of dermatology.

[44]  F. Simons,et al.  Effect of the H2-antagonist cimetidine on the pharmacokinetics and pharmacodynamics of the H1-antagonists hydroxyzine and cetirizine in patients with chronic urticaria. , 1995, The Journal of allergy and clinical immunology.

[45]  J. K. Walsh,et al.  Sleepiness and performance during three-day administration of cetirizine or diphenhydramine. , 1994, The Journal of allergy and clinical immunology.

[46]  S. Shuster,et al.  In dermographic urticaria H2 receptor antagonists have a small but therapeutically irrelevant additional effect compared with H1 antagonists alone , 1993, The British journal of dermatology.

[47]  D. Bernstein,et al.  Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria. , 1992, Arzneimittel-Forschung.

[48]  J. Donnez,et al.  Role of gonadotrophin-releasing hormone agonists in the treatment of external genital endometriosis: review of 77 cases. , 1992, Clinical therapeutics.

[49]  S. Tarlo,et al.  Chronic Urticaria , 1991, International journal of dermatology.

[50]  C. Kennedy,et al.  Cimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: a multi‐centre randomized double‐blind study , 1987, The British journal of dermatology.

[51]  K. Kauppinen,et al.  Cimetidine increases the plasma concentration of hydroxyzine. , 1986, Acta dermato-venereologica.

[52]  I. Björkhem,et al.  Prednisolone excretion in human milk. , 1985, The Journal of pediatrics.

[53]  J. Wegs,et al.  A controlled trial of therapy in chronic urticaria. , 1981, The Journal of allergy and clinical immunology.

[54]  J. Kalbfleisch,et al.  Combined H1 and H2 antihistamine therapy in chronic urticaria. , 1981, Archives of dermatology.